Alzheimer's drug may slow decline
Share
Tweet
Dreamstime
It's important to note the new treatment is not intended for all dementia patients -- only those who have mild cognitive impairment or mild dementia due to Alzheimer's disease.
The Food and Drug Administration has granted accelerated approval of a disease-modifying treatment that could potentially give some patients with Alzheimer's disease something they haven't had before: a medication that may slow the decline of memo...
For access to this article please
sign in or
subscribe.
